Citation tools
"<Sup>177</Sup>Lu and <Sup>225</Sup>Ac dose escalation using a novel class of PSMA radioligands with low salivary gland and kidney retention in a preclinical model of human prostate cancer." Journal of Nuclear Medicine
63.supplement 2
(2022):
2612.
Web. 02 May. 2025.